Kymera Therapeutics Presents New Preclinical Data for KT-579 Kymera Therapeutics, Inc. announced the presentation of new preclinical data for KT-579, a first-in-class, oral IRF5 degrader, …
Support for Furloughed Park Rangers in Utah A community in Utah is showing support for furloughed park rangers during the federal governme…
ASX Market Update The Australian stock market is experiencing a decline, led by heavy falls in the healthcare and tech sectors, despite se…
Utah's Olympic Organizers in NYC Leaders of Utah's 2034 Winter Games are in New York City to show support for American athletes competing …
Navigating Complex Injury Cases Efficiently Dealing with a serious injury case can be stressful and confusing, but there are steps you can…
Government Reveals Environmental Regulation Reforms The government has announced changes to environmental regulations in an effort to boos…
Isuzu FA Trophy Second Round Proper Draw Confirmed The draw for the Isuzu FA Trophy Second Round Proper has been announced, featuring 40 m…
Mor Schwartz Channels Olivia Newton-John and Dolly Parton Mor Schwartz brings the music of Olivia Newton-John and Dolly Parton to life in …
Zenas BioPharma Announces Positive Results from Phase 2 MoonStone Trial Zenas BioPharma, Inc. announced positive results from the Phase 2 …
Tin-top tales with Alain Menu Destined to become a vet, Swiss driver Alain Menu decided to follow his heart and headed for the track. …
CTD-ILD Burden on Older Patients and Women The incidence and prevalence of Connective Tissue Diseases with Interstitial Lung Disease (CTD-…